The Next Therapeutic Challenge in HIV: Polypharmacy
Edelman EJ, Gordon KS, Glover J, McNicholl IR, Fiellin DA, Justice AC. The Next Therapeutic Challenge in HIV: Polypharmacy. Drugs & Aging 2013, 30: 613-628. PMID: 23740523, PMCID: PMC3715685, DOI: 10.1007/s40266-013-0093-9.BooksConceptsAntiretroviral therapyHIV infectionSerious adverse drug eventsChronic antiretroviral therapyHarms of polypharmacyLifelong antiretroviral therapyRisk of polypharmacyCombination antiretroviral therapyNumber of medicationsAdverse drug eventsOrgan system injuryDecades of lifePhysiologic frailtyHIV patientsMore medicationsComorbid diseasesGeriatric syndromesImmune dysfunctionMedication adherenceMost HIVTherapeutic challengeChronic inflammationSystem injuryDrug eventsPolypharmacyPersonal Health Record Use and Its Association with Antiretroviral Adherence: Survey and Medical Record Data from 1871 US Veterans Infected with HIV
Keith McInnes D, Shimada SL, Rao SR, Quill A, Duggal M, Gifford AL, Brandt CA, Houston TK, Ohl ME, Gordon KS, Mattocks KM, Kazis LE, Justice AC. Personal Health Record Use and Its Association with Antiretroviral Adherence: Survey and Medical Record Data from 1871 US Veterans Infected with HIV. AIDS And Behavior 2013, 17: 3091-3100. PMID: 23334359, DOI: 10.1007/s10461-012-0399-3.Peer-Reviewed Original ResearchConceptsPersonal health record useMedical record dataPHR useAntiretroviral adherenceElectronic personal health record useVeterans Aging Cohort StudyRecord useHIV care processesMedication possession ratioAging Cohort StudyPharmacy refill dataRecord dataImproved patient outcomesCross-sectional surveyCohort studyPossession ratioDepression careRefill dataMedication adherenceUS veteransPatient outcomesAdherence measuresCare processesSocio-demographic variablesAdherence